Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 8,901 | 9,595 | 8,435 | 9,303 | 7,541 |
| Cost of Goods | 6,171 | 6,502 | 5,569 | 6,947 | 5,187 |
| Gross Profit | 2,730 | 3,093 | 2,866 | 2,356 | 2,354 |
| Operating Expenses | 4,197 | 5,682 | 4,542 | 4,571 | 3,892 |
| Operating Income | -1,296 | -2,087 | -1,106 | -1,268 | -1,351 |
| Interest Expense | 0 | -41 | 0 | 0 | 49 |
| Other Income | 76 | -241 | 124 | 431 | 138 |
| Pre-tax Income | -1,220 | -2,287 | -983 | -838 | -1,261 |
| Income Tax | -40 | -129 | 215 | -344 | 22 |
| Net Income Continuous | -1,180 | -2,158 | -1,198 | -494 | -1,284 |
| Net Income | $-1,180 | $-2,158 | $-1,198 | $-494 | $-1,284 |
| EPS Basic Total Ops | -4.40 | 55.60 | -9.40 | -99.40 | -20.00 |
| EPS Basic Continuous Ops | -4.36 | 55.71 | -9.45 | -99.40 | -20.02 |
| EPS Diluted Total Ops | -4.40 | 55.60 | -9.40 | -99.40 | -20.00 |
| EPS Diluted Continuous Ops | -4.36 | 55.71 | -9.45 | -99.40 | -20.02 |
| EPS Diluted Before Non-Recurring Items | -4.40 | N/A | -9.40 | N/A | N/A |
| EBITDA(a) | $-1,231 | $-2,022 | $-1,042 | $-1,217 | $-1,308 |